Viewing Study NCT06707493


Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2025-12-25 @ 11:16 PM
Study NCT ID: NCT06707493
Status: RECRUITING
Last Update Posted: 2025-10-17
First Post: 2024-11-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ivosidenib as Post-HSCT Maintenance for AML
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module